Congress orders study on opioid surveillance—but skips privacy safeguards
H.R. 2404 — Remote Opioid Monitoring Act of 2025 · Filed by Troy Balderson (R-OH) · 1 cosponsor · Introduced Mar 27, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs the Comptroller General (the federal government's chief auditor) to study remote monitoring systems for people prescribed opioids within 18 months and report findings to Congress. The study will assess whether remote monitoring works, how widely it is used, and recommend ways to expand access through federal health programs.
Why we flagged it
The bill is a straightforward directive for a government study on a specific health intervention. It does not create new law, regulation, or funding — only a fact-finding obligation with recommendations to follow.
What the text implies
- Study recommendations may lead to federal coverage mandates for remote monitoring, potentially expanding surveillance infrastructure in healthcare without explicit legislative debate on privacy protections.
- Identification of 'cohorts who benefit most' could enable targeted monitoring policies that disproportionately affect certain populations (e.g., low-income, racial minorities, or those with prior substance-use histories).
The full analysis lists 4 implications of this text.
Who stands to gain
remote monitoring technology vendors; health IT companies; telehealth platforms